Knowledge for Use in Practice

Knowledge for Use in Practice delves deep into medical research, providing practical solutions for pressing health concerns that impact all of society. This conference showcases cutting-edge developments in healthcare, ensuring that scientific breakthroughs are not just theoretical, but applied to create real-world health solutions.

The main sections of Knowledge for Use in Practice conference are highlighted below:

The Role of Dysregulated Immune Responses and Infection in Disease Pathology

26-28 March, Hippocrates Lecture Hall, RSU, 16 Dzirciema iela

26 March. Perspective Strategies to Overcome Antibacterial Resistance and Tackle Hard-to-Treat Infections

As the threat posed by multidrug-resistant pathogens intensifies, we find ourselves at a critical juncture where antibiotic treatment is increasingly ineffective. Phage therapy has emerged as a promising alternative and, in some instances, the only viable option for the patient. Unlike broad-spectrum antibiotics, phages target only specific bacteria, thus not disturbing the microbiota. The abundance of phages and their interaction with bacteria have shown that phages could complement or even replace antibiotics in the fight against infections. The research in phage application in medicine and other spheres is flourishing and has demonstrated immense potential for the future treatment of difficult-to-treat infections.

27 March. Immunology and Neuroimmunology in Research and Clinical Practice 

This section focuses on the comprehensive study of primary immunodeficiencies and autoimmune diseases, with a particular emphasis on neurological autoimmune disorders and their complex underlying pathogenesis. It also delves into the investigation of hereditary angioedema and chronic spontaneous urticaria, two key areas in the study of immunological disorders. Additionally, the section explores various forms of allergies and secondary immunodeficiencies, examining their triggers, mechanisms, and impacts on the immune system. Through a multidisciplinary approach, this research seeks to advance the understanding of these conditions and contribute to the development of innovative diagnostic and therapeutic strategies.

28 March. Infection Associated Non-Communicable Diseases

"Infection associated non-communicable diseases" delves into the critical role of infections in the onset and progression of non-communicable diseases, emphasizing how host-pathogen interactions contribute to autoimmune conditions. Topics will include the latest research on infections as triggers for chronic diseases, the discovery of novel biomarkers, and cutting-edge detection methods. Through these discussions, the section aims to illuminate the connections between infectious processes and long-term health outcomes, driving forward both research and clinical strategies.

Keynote Speakers

Perspective Strategies to Overcome Antibacterial Resistance and Tackle Hard-to-Treat Infections

Scientific Committee

Perspective Strategies to Overcome Antibacterial Resistance and Tackle Hard-to-Treat Infections

• Jean-Paul Pirnay, PhD, Queen Astrid Military Hospital, Head of the Laboratory for Molecular and Cellular Technology, Belgium
• Asst. prof. Saija Kiljunen, PhD, Human Microbiome Research Program, Faculty of Medicine, University of Helsinki PrecisionPhage Ltd, Jyväskylä, Finland
• Prof. Krystyna Dabrowska, PhD, Laboratory of Phage Molecular Biology, Institute of Immunology and Experimental Therapy, Wrocław, Wrocław University of Science and Technology, Faculty of Medicine, Wrocław, Research and Development Center, Regional Specialist Hospital, Wrocław, Poland
• Prof. Juta Kroiča, MD, PhD, Department of Biology and Microbiology, Rīga Stradiņš University
• Prof. Ludmila Vīksna, Md, PhD, Department of Infectology, Rīga Stradiņš University; Riga East University Clinical Hospital
• Asst. Prof. Kārlis Rācenis, MD, PhD, Department of Biology and Microbiology, Department of Internal Diseases, Rīga Stradiņš University; Nephrology Centre, Pauls Stradins Clinical University Hospital
• Researcher Ņikita Zrelovs, PhD, Department of Biology and Microbiology, Rīga Stradiņš University, Latvian Biomedical Research and Study Centre
• Asst. prof. Monta Madelāne, MD, PhD, Department of Infectology, Rīga Stradiņš University; Department of Infection Control, Riga East University Clinical Hospital

Immunology and neuroimmunology in Research and clinical practice

• Prof. Kai Kisand, Cellular Immunology at the Institute of Biomedicine and Translational Medicine, the University of Tartu, Estonia 
• Prof. Aurelija Žvirbliene, Head of the Department of Immunology and Cell Biology, Institute of Biotechnology of Vilnius University 
• Shahar Shelly,  MD, PhD, Director of Neuromuscular centre, Institute of Pathology, Rambam Medical Center, Haifa, Israel
• Prof. Nataļja Kurjāne, Department of Biology and Microbiology, Rīga Stradiņš University; lead researcher at the Scientific Laboratory of Molecular Genetics, RSU; Head of the Centre of Clinical Immunology and Allergology, Pauls Stradins Clinical University Hospital
• Assoc. Prof. Viktorija Ķēniņa, Department of Biology and Microbiology, Rīga Stradiņš University; lead researcher at the Scientific Laboratory of Molecular Genetics; Head of the Centre of Rare Neurological diseases,  Pauls Stradins Clinical University Hospital
• Dr. med. Zaiga Nora-Krūkle, Director, Institute of Microbiology and Virology, Rīga Stradiņš University

Infection Associated Non-Communicable Diseases

• Dr. med. Zaiga Nora-Krūkle, Director, Institute of Microbiology and Virology, Rīga Stradiņš University
• Dr. med. Modra Murovska, Lead Researcher, Institute of Microbiology and Virology, Rīga Stradiņš University
• Dr. med. Šimons Svirskis, Lead Researcher, Institute of Microbiology and Virology, Rīga Stradiņš University
• Dr. med. Alīna Sultanova, Lead Researcher, Institute of Microbiology and Virology, Rīga Stradiņš University
• Asst. Prof. Dr. med. Anda Kadiša, Lead Researcher, Institute of Microbiology and Virology, Rīga Stradiņš University
• Dr. biol. Irina Holodņuka, Lead Researcher, Institute of Microbiology and Virology, Rīga Stradiņš University
• Dr. med. Bhupesh Kumar Prusty, Tenured Professor, Institute of Microbiology and Virology, Rīga Stradiņš University
• Gilad Halpert, The Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Israel
• Prof. Dario Di Luca, Dept. Medical Sciences, University of Ferrara, Italy
• Daria Bortolotti, Department of Chemical, Pharmaceutical and Agricultural Science, University of Ferrara, Italy
• Prof. Marion Schneider, Clinic for Anaesthesiology and Intensive Care Medicine, Ulm University Hospital, Germany

Main Topics

• Clinical microbiology 
• Vaccination 
• Antimicrobial resistance 
• Nosocomial infections 
• Treatment methods for hard-to-treat infections 
• Phage therapy 
• Immunology 
• Neuroimmunology 
• Host-pathogen interaction 
• Infections in the development of non-communicable diseases 
• Autoimmunity

Treatment and Quality Improvement in Healthcare 

26-28 March, Auditorium #3, RSU, 16 Dzirciema iela

26 March. Oncology and Hematology – Biomarker-Driven Precision Medicine

In the session distinguished international faculty and local cancer experts/researchers will present the results of their latest studies. Mirjam Blattner-Johnson will give an update in the advances in pediatric brain tumor research. Prof. Jacek Gronwald and Prof. Arcangela De Nicolo will uncover cutting edge studies on BRCA1/2 carriers – both clinical and molecular aspects in prevention and management of cancer. The topics in personalized cancer medicine and biomarkers research will include genetic population screening of hereditary breast and ovarian cancer, epidemiology and phenotype/genotype correlations of breast and ovarian cancer predisposition genes, as well as microbiome studies during the cancer treatment.

27 March. Transforming Care: Treatment Quality Improvement in Kidney Disease and Beyond

This session will explore the comprehensive utility of kidney disease registries in understanding disease progression, optimizing treatment responses, and assessing cost-effectiveness in chronic kidney disease (CKD) management. Discussions will delve into cutting-edge research on IgA nephropathy (IgAN) pathogenesis, highlighting the pivotal roles of B cells and other biomarkers. The use of renal biopsy registries for detailed analysis of IgAN progression will be examined, alongside strategies for effective disease surveillance and quality control in chronic conditions. Attendees will gain a comprehensive understanding of how registry data can drive advancements in both scientific research and clinical practice.

28 March. Rare Diseases

The Rare Disease Session will address the current challenges and advancements in rare disease research and management both in Latvia and globally. The session will conclude with a clinically focused discussion on selected rare disease case reports, providing practical insights for healthcare professionals.

Keynote Speakers

Transforming Care: Treatment Quality Improvement in Kidney Disease and Beyond

Scientific Committee

Oncology and Hematology – Biomarker-Driven Precision Medicine

• Prof. Arvīds Irmejs, Institute of Oncology and Molecular Genetics, Rīga Stradiņš University
• Prof. Zanda Daneberga, Institute of Oncology and Molecular Genetics, Rīga Stradiņš University
• Prof. Jānis Gardovskis, Department of Surgery, Faculty of Medicine, Rīga Stradiņš University
• Prof. Sandra Lejniece, Dean, Department of Doctoral Studies / Department of Internal Diseases, Rīga Stradiņš University
• Prof. Edvīns Miklaševičs, Faculty of Medicine, Department of Biology and Microbiology, Rīga Stradiņš University

Transforming Care: Treatment Quality Improvement in Kidney Disease and Beyond

• Prof. Alberto Ortiz, MD, PhD, Autonomous University of Madrid, Spain; Chief of Nephrology and Hypertension at Fundacion Jimenez Diaz University Hospital and Health Research Insitute (IIS-FJD UAM), Madrid, Spain 
• Prof. Kitty J. Jager, MD, PhD, Department of Medical Informatics at Amsterdam University Medical Center, Netherlands
• Assoc. Prof. and Principal Investigator Vianda S. Stel PhD, Department of Medical Informatics at Amsterdam University Medical Center, Netherlands; European Renal Association Registry Managing Director
• Assoc. Prof. Sabine Leh, MD, PhD, Department of Clinical Medicine, University of Bergen; Department of Pathology, Haukeland University Hospital; Registry pathologist, Norwegian Renal Registry.
• Prof. Aivars Pētersons, MD, PhD, Department of Internal Diseases, Rīga Stradiņš University; Nephrology Centre, Pauls Stradins Clinical University Hospital
• Assoc. Prof. Viktorija Kuzema, MD, PhD, Department of Internal Diseases, Rīga Stradiņš University; Nephrology Centre, Pauls Stradins Clinical University Hospital; Head of Latvian Kidney Replacement Therapy Patient Registry
• Assist. prof. Kristīne Oļeinika, PhD, Department of Internal Diseases, Rīga Stradiņš University; Postdoctoral Research Fellow, Program in Cellular and Molecular Medicine, Boston Children’s Hospital, Harvard Medical School, Boston, MA, USA
• Assist. Prof. Kārlis Rācenis, MD, PhD, Department of Biology and Microbiology, Department of Internal Diseases, Rīga Stradiņš University; Nephrology Centre, Pauls Stradins Clinical University Hospital

Rare Diseases

• Assoc. Prof. Andris Skride, Rīga Stradiņš University
• Assoc. Prof. Madara Auzenbaha, Rīga Stradiņš University
• Dr. med. Linda Gailīte, Rīga Stradiņš University
• Dr. med. Ainārs Rudzītis, Rīga Stradiņš University
• Prof. Aivars Lejnieks, Rīga Stradiņš University
• Dr. Valdis Ģībietis, Rīga Stradiņš University

Main Topics

Oncology and Hematology – Biomarker-Driven Precision Medicine

• Oncology
• Hematology
• Coagulation and Hemostasis 

Transforming Care: Treatment Quality Improvement in Kidney Disease and Beyond  

• IgA nephropathy 
• Immunology in renal diseases
• B cell immunity
• Surveillance of chronic kidney disease 
• Kidney disease registries
• Renal replacement therapy (hemodialysis, peritoneal dialysis, kidney transplantation) 
• Predialysis program

Rare Diseases

• Epidemiology and Natural History of Rare Diseases
• Diagnostic Challenges and Advances in Rare Diseases
• Innovative Therapies and Treatments for Rare Diseases
• Regulatory and Policy Issues in Rare Disease Research and Treatment
• Rare Disease Case Reports

Metabolism and Cardiovascular Diseases

26-27 March, Auditorium #1, RSU, 16 Dzirciema iela

26 March. Arrhythmias, Cardiomyopathies, Invasive Cardiology, Cardiac Surgery

The session will address emerging therapies and current research in the field of cardiac arrhythmias, sports medicine, cardiomyopathies, interventional cardiology and cardiac surgery. Among the best selected abstracts there will be state-of-the-art lectures presented by local and international faculty.

27 March. Integrative Biomarker-Based Prevention of Cardiovascular and Metabolic Diseases, Personalized Therapy, and Identification of Drug Targets 

Biomedicine is recognized as one of the priorities for national research investments according to the Smart Specialization Strategy for Research and Innovation. For implementing this strategy an ambitious and unique project was carried out in 2023-2024 - State research project in the field of biomedicine, medical technologies and pharmacy.
The mission statement of this Project is:  improving access to treatment for reduction of mortality or morbidity rates and improved health conditions through the development of medicinal products and their manufacturing technologies, transport forms and vaccines, repurposing of marketed drugs, the drug discovery and development, as well as the identification of new biomarkers and the development of a precision medical solution
The implementation of the Project was performed in separate work packages (WP) by collaborative efforts of the consortium partners.  The WP2 "Integrative biomarker-based prevention of cardiovascular and metabolic diseases, personalized therapy, and identification of drug targets" aims to create new techniques and methods of personalized monitoring, diagnostic and treatment, aiming to promote implementation of the latest scientific discoveries and modern technologies into a clinical practice to improve survival and quality of life of Latvian population.

This project combine clinical medicine competencies of University of Latvia  (cardiovascular medicine) and Rīga Stradiņš University (metabolic diseases and neonatal medicine) with preclinical pharmacology expertise of the Latvian Institute of Organic Synthesis  and molecular biology research achievements of Latvian Biomedical Research and Study Centre.  
The following tasks were implemented during the  project: 

1. direct diagnostic accuracy comparison of intravascular ultrasound (IVUS), optical coherence tomography (OCT) and near infrared spectrometry (NIRS) for the detection and characterization of coronary plaque composition, including determination of atherosclerotic plaque rupture risk by positron emission tomography (PET/CT); 
2. evaluation of the expression of atherosclerosis related microRNAs and their correlation with unfavorable atherosclerotic plaque characteristics. 
3. evaluation of the effect of statins on acylcarnitine metabolism as a possible mechanism of statin associated myopathy (SAM); 
4. optimization of triple hormone administration to maximize weight loss, increase resting metabolic rate and to control blood glucose. 
5. search for new, sensitive prognostic biomarkers that can be implemented in clinical practice for the development of non-invasive testing algorithms for the early diagnosis, evaluation, and prognosis of life-threatening diseases in newborns. 
6. investigation of the opportunities to increase omega-3 PUFA content by inhibition of their metabolism; 
7. selection of anti-sense oligonucleotide candidates for the treatment of the calpainopathy. 

Today's conference is dedicated to the results of the above-mentioned research included in the WP2 package, their analysis and the perspective of further research.

(Integratīva biomarķieros balstīta kardiovaskulāro un metabolo slimību prevencija, personalizēta terapija un zāļu mērķu identificēšana) -  Ekonomikas ministrijas VPP-EM-BIOMEDICĪNA.  

Keynote Speakers

Scientific Committee

• Prof. Aivars Lejnieks MD, PhD, Department of Internal Diseases, Riga Stradin’s University, Riga East University Hospital 
• Prof. Ilze Konrāde MD, PhD, Department of Internal Diseases, Riga Stradin’s University, Riga East University Hospital
• Maija Dambrova, Dr. pharm. Professor in the Department of Pharmaceutical Chemistry, Riga Stradins University; Head of Laboratory of Pharmaceutical Pharmacology, Latvian Institute of Organic Synthesis; Full Member of the Latvian Academy of Sciences
• Prof. Dace Gardovska MD, PhD, Department of Pediatrics, Riga Stradin’s University, Riga East University Hospital
• Prof. Oskars Kalējs, Rīga Stradiņš University
• Prof. Pēteris Stradiņš, Rīga Stradiņš University
• Dr. med. Mārtiņš Kalējs, Rīga Stradiņš University
• Prof. Andris Skride, Rīga Stradiņš University
• Dr. med. Ainārs Rudzītis, Rīga Stradiņš University
• Prof. Maija Radziņa, Rīga Stradiņš University
• Prof. Aleš Linhart, Charles University in Prague, Czech Republic
• Dr. med. Manuel Wilbring, Dresden University Hospital, Germany
• Prof. Andrejs Ērglis MD, PhD, Faculty of Medicine and Life Sciences, University of Latvia, Paula Stradin’s Clinical University Hospital 
• Vilnis Dzērve MD, PhD, Faculty of Medicine and Life Sciences, University of Latvia
• Prof. Gustavs Latkovskis MD, PhD, Faculty of Medicine and Life Sciences, University of Latvia, Paula Stradin’s Clinical University Hospital
• Osvalds Pugovics Dr. chem., Latvian Institute of Organic Synthesis
• Edgars Liepiņš, Dr. pharm., Principal Scientist at the Laboratory of Pharmaceutical Pharmacology, Latvian Institute of Organic Synthesis; Full Member of the Latvian Academy of Sciences

Main Topics

• Metabolism and cardiovascular diseases
• Arrhythmology
• Genetics in cardiology
• Cardiomyopathies
• Interventional cardiology
• Cardiac surgery

Sport Science, Sport Medicine and Rehabilitation

26–28 March, Auditorium #2, RSU, 16 Dzirciema iela

The Sport Science, Sport Medicine and Rehabilitation section will focus on actual topics within these disciplines as well as cover interdisciplinary issues related to the latest achievements in exercise physiology and training methods, use of technologies in sport and rehabilitation, factors related to high achievement sport as well as everyday physical activities and rehabilitation process.

Keynote speakers

Scientific Committee

• Prof. Inga Millere, Dean, Faculty of health and Sport Sciences, Rīga Stradiņš University, Latvia
• Prof. Aija Kļaviņa, Lead researcher, Rīga Stradiņš University, Latvia
• Assoc. Prof. Signe Tomsone, Department of Rehabilitation, Rīga Stradiņš University, Latvia
• Assoc. Prof. Kalvis Ciekurs, Latvian Academy of Sport Education, Riga Stradiņš University, Latvia
• Asst. Prof. Dace Reihmane, Lead researcher, Laboratory of Sports and Nutrition Research, Rīga Stradiņš University, Latvia
• Dr Sandra Rozenštoka, Lead Researcher, Institute of Public Health,  Rīga Stradiņš University, Latvia
• Prof. Flemming Dela, Xlab, Center for Healthy Aging, University of Copenhagen, Denmark
• Prof. Bart Roelands, Human Physiology and Sports Physiotherapy Research Group, Vrije Universiteit, Belgium
• Prof. Susanna Hedenborg, Professor of Sports Science and Associate Professor in Social and Economic History, Malmo University, Sweden
• Prof. Fabio Pigozzi, he President of International Sports Medicine Federation, Professor of Sport Sciences, University of Rome “Foro Italico”, Italy
• Prof. Yannis Pitsiladis, The Chairman of Scientific committee of the European Federation of Sports Medicine Associations, Professor of Sport and Exercise Science, University of Brighton, United Kingdom
• Prof. Matteo Lancini, Mechanical and Thermal Measurement Laboratory, University of Brescia, Italy 
• Assoc. Prof. Amelia Guadalupe-Grau, Universidad de Castilla-la Manch, Spain

Main Topics

• Sport science
• Sport medicine
• Rehabilitation

Women's and Children's Health 

26-27 March, Room 204, RSU, 21 Konsula iela

26 March. Empowering Women’s Health, Bridging Gaps, Advancing Care

The main topics of the section Empowering Women’s Health, Bridging Gaps, Advancing Care are dedicated to the challenges of modern sexual and reproductive medicine, obstetrics, and gynecology. Together with world-renowned experts, we will discuss current issues in pregnancy termination, evidence-based obstetric practice, success in eradicating cervical cancer, the importance of the quality of sexual life in a woman's health, and advances in ultrasonography

27 March. Children and Infections - Forever Together, but the Dimension is Changing

The comprehensive scientific programme of section “Children and infections - forever together, but the dimensions are changing” will give valuable insights into the latest advances of research and developments in paediatric infectious diseases combined with practice-changing updates in care of children with infections.
Participants of the section will have the opportunity to attend lectures given by leading researchers and practitioners in the pediatric infectious field. All the topics will be presented and discussed from multiple perspectives allowing each participant to gain knowledge. Results from extensive research of tick borne encephalitis (TBE) in Latvia as well as several EU Horizon 2020 projects which paved the way for the latest DIAMONDS project will be presented to demonstrate the long-term research process of developing a molecular test for the rapid diagnosis of serious infectious and inflammatory diseases using personalised gene signatures. Within the framework of these projects, findings from Emergency departments across Europe alongside national data from Latvia will be presented to bring research close to clinic. 
Furthermore, we encourage participants to share their research interests at the Poster section to interact with other colleagues, exchange ideas and foster new collaboration. We encourage to submit posters on the following topics:

• Paediatric infectious diseases
• Fever in children
• Tick borne encephalitis

You will have an opportunity to meet passionate researchers, network with colleagues with similar interests, gain cutting-edge knowledge with the ultimate and common aim to improve care for our children. 

Keynote Speakers

Scientific Committee

• Prof. Gerhard Dobler, Bundeswehr Institute of Microbiology, German National Consultant Laboratory for TBEV, Munich, Germany; Dept. of Tropical Medicine and Infectious Diseases, Ludwig-Maximilians-Universität, Munich, Germany; Dept. of Parasitology, University of Hohenheim, Stuttgart, Germany
• Prof. Henriette Moll, Erasmus MC – Sophia Children’s Hospital, The Netherlands
• Prof. Dace Zavadska, Rīga Stradiņš University
• Prof. Jana Pavāre, Rīga Stradiņš University

Main Topics

Children's health 

• Children and infections 
  • Pediatric infectious diseases 
  • Fever in children 
• Pediatrics 
• Neonatology  

Women's health

• Sexual and reproductive health and rights
• Pregnancy and delivery care 
• Gynecology
• Ultrasound in obstetrics and gynecology
• Infertility
• Gynecological oncology and cancer prevention

Innovation in Medicine and Healthcare – from Research to Practice

26–27 March, Lobby, RSU, 21 Konsula iela

Rīga Stradiņš University Innovation section focuses on exploring Digital Transformation in Healthcare, showcasing advancements in Precision Medicine, Telemedicine  and Digital Innovations. The event gathers experts to discuss the latest in telemedicine, enhancing patient care through cutting-edge technology. Attendees gain insights into integrating digital tools to revolutionize healthcare delivery. Workshops and presentations emphasise the role of innovation in improving health outcomes and efficiency.

Scientific Committee

• Assoc. Prof. Dins Šmits, Vice-Rector for Academic Affairs, Rīga Stradiņš University
• Lauris Vidzis, Chief Executive Officer, Pauls Stradins Clinical University Hospital 
• Baiba Ziemele, Chairman of the board Latvian, Network of Patient Organizations 

Main Topics

• Digital Transformation in Healthcare
• Precision medicine
• Digital innovations
• Telemedicine

Innovative Dosage Forms and Drug Delivery Systems

27 March, Room 305, RSU, 21 Konsula iela

Keynote Speakers

Scientific Committee

• Asst. Prof. Agnese Brangule, Department of Pharmaceutical Chemistry, Rīga Stradiņš University
• Konstantīns Logviss, Head of Laboratory of Finished Dosage Forms, Rīga Stradiņš University
• Assoc. Prof. Baiba Mauriņa, Vice-Dean, Faculty of Pharmacy, Rīga Stradiņš University
• Valentyn Mohylyuk, Leading visiting researcher, Faculty of Pharmacy, Rīga Stradiņš University
• Asst. Prof. Inga Urtāne, Head of Department of Pharmaceutical Chemistry, Rīga Stradiņš University
• Prof. Valdas Jakštas, Lithuanian University of Health Sciences (LSMU)

Main Topics

• Pharmaceutical Science
• Drug delivery systems 

Dental and Maxillofacial Sciences

 28 March, Room 305, RSU, 21 Konsula iela

Dental and Maxillofacial Sciences will focus on medical research, integrating cutting-edge technology and interdisciplinary approaches to improve patient care and outcomes in the oral and maxillofacial regions, innovations and translating scientific discoveries.

Main Topics

• Dentistry and related sciences
• Oral and Maxillofacial Surgery
• Biomaterials

Scientific Committee

Prof. Ilze Akota, Rīga Stradiņš University
Prof. Ingrīda Čēma, Rīga Stradiņš University
Asoc. prof. Laura Neimane, Rīga Stradiņš University
Asoc.prof. Andris Ābeltiņš, Rīga Stradiņš University
Doc. Ilze Šalma, Rīga Stradiņš University
Prof. Ulvi Gursoy, Turku University, Finland

From Past to Modern Morphology

28 March, Room 204, RSU, 21 Konsula iela

The beauty of Histology reveals the inside of tissue and organs, but the other subdiscipline of Morphology – Anthropology displays the magnificence of body changes in external shape during the centuries. These subjects never persist separately but overlap with developmental Biology and Histopathology resulting in whole Morphology science. Thus, this section will focus on polymorphous Morphology including even an artificial intelligence and 3D printing aspects of nowadays subject.

Keynote Speakers

Scientific & Organizing Work Groups

Scientific Work Group

• Prof. Māra Pilmane, Rīga Stradiņš University
• Andrejs Ivanovs, MD MSc PhD MRCP(UK) FRCPath, Department of Haematology, Edinburgh Cancer Centre, UK

Organizing Work Group

• Prof. Māra Pilmane, Rīga Stradiņš University
• Asst. Prof. Anna Junga, Rīga Stradiņš University
• Assoc. Prof. Dzintra Kažoka, Rīga Stradiņš University

Main Topics

• Anthropology
• Histology
• Embryology and Teratology
• Histopathology